Volume 11, Number 8—August 2005
Spoligotyping and Mycobacterium tuberculosis
|Median (range)||34 (3–88)|
|Sex, no. (%)|
|Type of patient, no. (%)|
|Infectious diseases||124 (83.8)|
|Internal medicine||10 (6.8)|
|HIV status, no. (%)|
|CD4+ cell count/μL†|
|Mean (range)||105 (1–589)|
|Previous tuberculosis, no. (%)||20 (13.5)|
|Previous MAC infection, no. (%)
|No tuberculosis or MAC infection, no. (%)||118 (79.7)|
*MAC, Mycobacterium avium complex.
†Data available for 90 of 96 HIV-infected patients.
Page created: April 23, 2012
Page updated: April 23, 2012
Page reviewed: April 23, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.